Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.47 |
| ▸ | HTR2A | P28223 | 2/20 | 0.40 |
| ▸ | HTR2C | P28335 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3522893 | 1.00 | KCNN4 (0.47) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL30456862 | 1.00 | KCNN4 (0.47) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL3527440 | 0.78 | KCNN4 (0.43) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL3522115 | 0.76 | KCNN4 (0.52) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL27183395 | 0.76 | KCNN4 (0.57) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL1871740 | 0.71 | KCNN4 (0.47) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL6369689 | 0.69 | KCNN4 (0.57) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL30114522 | 0.69 | CYP3A4 (0.60) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL2131459 | 0.69 | CYP3A4 (0.60) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL8157067 | 0.68 | KCNN4 (0.61) | KCNN4HTR2AHTR2COPRK1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248672-A1 | COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES | ADIMABIO LLC (US) | 2023-08-10 | — | — | US | claimed |
| WO-2018162426-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2018-09-13 | — | — | WO | claimed |
| US-20180136227-A1 | Treatment and Diagnosis of Hereditary Xerocytosis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-05-17 | — | — | US | claimed |
| EP-3307252-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | Universite d'Aix Marseille (FR) | 2018-04-18 | — | — | EP | claimed |
| WO-2016202854-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | UNIVERSITE D'AIX-MARSEILLE (FR) | 2016-12-22 | — | — | WO | claimed |
| EP-3106155-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | Universite d'Aix Marseille (FR) | 2016-12-21 | — | — | EP | claimed |
| US-20250000887-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | AKIRABIO, INC. (US) | 2025-01-02 | — | — | US | disclosed |
| US-11938143-B2 | Compositions comprising 2′-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers | AKIRABIO, INC. (US) | 2024-03-26 | — | — | US | disclosed |
| WO-2023069529-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | AKIRABIO, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| US-20230123277-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE AND THALASSEMIA | AKIRABIO INC (US) | 2023-04-20 | — | — | US | disclosed |
| US-20230122664-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | CUSTOMERS BANK | 2023-04-20 | — | — | US | disclosed |
| US-20230055298-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | ADIMABIO LLC | 2023-02-23 | — | — | US | disclosed |
| WO-2018162426-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2018-09-13 | — | — | WO | disclosed |
| US-20180136227-A1 | Treatment and Diagnosis of Hereditary Xerocytosis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-05-17 | — | — | US | disclosed |
| EP-3307252-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | Universite d'Aix Marseille (FR) | 2018-04-18 | — | — | EP | disclosed |
| WO-2016202854-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | UNIVERSITE D'AIX-MARSEILLE (FR) | 2016-12-22 | — | — | WO | disclosed |
| EP-3106155-A1 | TREATMENT AND DIAGNOSIS OF HEREDITARY XEROCYTOSIS | Universite d'Aix Marseille (FR) | 2016-12-21 | — | — | EP | disclosed |
| US-7709533-B2 | Imines as ion channel modulators | ICAGEN, INC. (US) | 2010-05-04 | — | — | US | disclosed |
| US-20060178346-A1 | Imines as ion channel modulators | ICAGEN, INC. (US) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230122664-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | TYMP, HBZ, HBB | KCNN4 3715/4885HTR2A 1234/4885HTR2C 1554/4885 |
| US-11938143-B2 | Compositions comprising 2′-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers | TYMP, HBZ, CDA | KCNN4 3745/4885HTR2A 1146/4885HTR2C 1463/4885 |
| US-20230248672-A1 | COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES | CACNA1G, CACNA1I, CACNG2 | KCNN4 36/4885HTR2A 554/4885HTR2C 1046/4885 |
| US-20250000887-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | TYMP, HBZ, HBB | KCNN4 3715/4885HTR2A 1234/4885HTR2C 1554/4885 |
| US-20060178346-A1 | Imines as ion channel modulators | KCNN1, KCNN3, KCNN2 | KCNN4 4/4885HTR2A 1212/4885HTR2C 1436/4885 |
| US-20230055298-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | TYMP, HBZ, HBB | KCNN4 3715/4885HTR2A 1234/4885HTR2C 1554/4885 |
| US-20230123277-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE AND THALASSEMIA | HBB, HBZ, TYMP | KCNN4 3612/4885HTR2A 1436/4885HTR2C 1808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.